Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2025-12-29 @ 9:08 PM
Study NCT ID:
NCT06082635
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-18
First Post:
2023-10-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Shenzhen TargetRx, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TGRX-326-3001-NSCLC-CN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |